"Current medical practices are like Blockbuster and stem cells are like an emerging Netflix type practice that could render many businesses obsolete."
Don't dispute that at all- ANYTHING is possible in this world and with a new area of "potential" and "yet unproven" science. Question is- how much mulah-cash-money and how much time? BHRT is in a game of beat the clock right now IMO. They decided to go from the "clinical lab" stage where many of these potential products/ideas are still at (and where many of the experts working on them are still saying time frames of like 8 to 15 yrs out to a "product", if ever), but BHRT decided to move to the commercialization arena earlier on, believing they had the "goods", but that has yet to be proven, and in the mean time their money has largely run out IMO and they are not finding a "funder" yet for these old (4 to 5 yr old) trials now? Why is that? What does the investment community see in those trials that stopped um at the phase II/III transition- the "zone" where they're about to cost the most money - the ole final phase III arena? There were side effects and "other" issues as noted in the BHRT 10-K filings- maybe someone isn't ready to pony up money for that risk yet? Who knows? But no "funder" has come forward yet to advance these trials and the stock sank from $5 or so, to now sub 3 cents, while dilution has continued unabated at a furious rate. Why?
That's the $64,000 or million or billion dollar question IMO. Remember too- ole Netflix is on the verge of getting crushed like a bug on a windshield, the day Google or Apple or Comcast or Time Warner someone with that kind of horsepower decides the "Netflix model" is valuable enough and "works" and is a profit generator. Netflix has yet to put a cable company out of biz- not even close. Netflix' biggest problem is now everyone is putting the squeeze on to pay for good content- and guess who holds a lot of the control over content? The "big boys" -the same old club. The best Netflix can hope for then is to be bought out at a lucrative enough price- one never knows when the "Big boys" will buy you or crush you. Microsoft used to do a lot of "crushing", these days there seems to be more "buying" - but who knows?
